This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Majid Ali, MD; A. Olusegun Fayemi, MD; Robert Rigolosi, MD; Joseph Frascino, MD
Holy Name Hospital Teaneck, NJ

JAMA. 1981;246(3):214-215.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—

All of our patients with dialysis siderosis received intravenous iron dextran. We agree with Bregman and colleagues that iron dextran appears to be the principal cause of the dissociation between the hepatic and the bone marrow iron in these patients. However, this may not be the sole cause of this phenomenon. Recently, we observed this paradox of hepatosplenic siderosis and marrowiron depletion in nondialysis patients with liver cirrhosis.

Other published observations of Bregman et al¹ concerning HLA-linked iron overload, myopathy, marrow iron, and serum ferritin are in basic alignment with ours. They furnish no data concerning hepatic iron stores. Their argument seems to center about the validity of the serum ferritin as a marker of bone marrow iron. Since our aforementioned study, we have reported the association of high serum ferritin levels and depletion of marrow iron stores in ten of 36 dialysis patients with hepatosplenic siderosis. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?